Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Operating Expenses (2016 - 2025)

Apyx Medical (APYX) has disclosed Operating Expenses for 15 consecutive years, with $12.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses changed 0.16% year-over-year to $12.0 million, compared with a TTM value of $39.5 million through Dec 2025, down 18.07%, and an annual FY2025 reading of $39.5 million, down 18.07% over the prior year.
  • Operating Expenses was $12.0 million for Q4 2025 at Apyx Medical, up from $9.1 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $14.7 million in Q4 2023 and bottomed at $8.7 million in Q1 2025.
  • Average Operating Expenses over 5 years is $12.1 million, with a median of $12.3 million recorded in 2021.
  • The sharpest move saw Operating Expenses surged 41.92% in 2021, then crashed 30.63% in 2025.
  • Year by year, Operating Expenses stood at $13.8 million in 2021, then grew by 2.39% to $14.2 million in 2022, then grew by 3.68% to $14.7 million in 2023, then dropped by 18.29% to $12.0 million in 2024, then decreased by 0.16% to $12.0 million in 2025.
  • Business Quant data shows Operating Expenses for APYX at $12.0 million in Q4 2025, $9.1 million in Q3 2025, and $9.7 million in Q2 2025.